Cargando…

Prognostic Value of Epidermal Growth Factor Receptor Mutations in Resected Non-Small Cell Lung Cancer: A Systematic Review with Meta-Analysis

BACKGROUND: The prognostic value of epidermal growth factor receptor (EGFR) mutations in resected non-small cell lung cancer (NSCLC) remains controversial. We performed a systematic review with meta-analysis to assess its role. METHODS: Studies were identified via an electronic search on PubMed, Emb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhixuan, Wang, Ting, Zhang, Jun, Cai, Xiaohong, Pan, Changchuan, Long, Yu, Chen, Jing, Zhou, Chengya, Yin, Xude
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146589/ https://www.ncbi.nlm.nih.gov/pubmed/25162713 http://dx.doi.org/10.1371/journal.pone.0106053

Ejemplares similares

Extent of Visceral Pleural Invasion Affects Prognosis of Resected Non-small Cell Lung Cancer: A meta-analysis
por: Wang, Ting, et al.
Publicado: (2017)

Epidermal Growth Factor Receptor Mutations and Their Prognostic Value with Carcinoembryonic Antigen in Pathological T1 Lung Adenocarcinoma
por: Zhu, Wang-Yu, et al.
Publicado: (2018)

Clinicopathologic features and prognostic value of epidermal growth factor receptor mutation in patients with pT1a and pT1b invasive lung adenocarcinoma after surgical resection
por: Chen, Shiqi, et al.
Publicado: (2021)

The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer
por: Guo, Meng, et al.
Publicado: (2016)

Prognostic value of epidermal growth factor receptor expression in operable non-small cell lung carcinoma
por: Seyhan, Ekrem Cengiz, et al.
Publicado: (2010)

Prognostic significance of pretreatment elevated platelet count in patients with colorectal cancer: a meta-analysis
por: Long, Yu, et al.
Publicado: (2016)

Limitations in the Use of Serum Epidermal Growth Factor Receptor Mutations as Prognostic Markers for Non-Small-Cell Lung Cancer
por: Zhang, Yongjun, et al.
Publicado: (2015)

Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma
por: Wang, Jinn-Li, et al.
Publicado: (2018)

The expression and prognostic value of the epidermal growth factor receptor family in glioma
por: Xu, Bin, et al.
Publicado: (2021)

Function and mode of action of cytohesins in the epidermal growth factor pathway in colorectal cancer cells
por: PAN, TAO, et al.
Publicado: (2013)

Evaluating the Prognostic Value of ERCC1 and Thymidylate Synthase Expression and the Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma Non-Small-Cell Lung Cancer
por: Lin, Chang-Sheng, et al.
Publicado: (2017)

Epidermal Growth Factor Receptor Mutations in Resectable Non-Small Cell Lung Cancer Patients and their Potential Role in the Immune Landscape
por: Xia, Wei, et al.
Publicado: (2019)

New prognostic system specific for epidermal growth factor receptor-mutated lung cancer brain metastasis
por: Zhu, Li-Hua, et al.
Publicado: (2023)

Prognostic value of sarcopenia in patients with lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors
por: Lyu, Jiahua, et al.
Publicado: (2023)

Deep learning for predicting epidermal growth factor receptor mutations of non-small cell lung cancer on PET/CT images
por: Xiao, Zhenghui, et al.
Publicado: (2023)

The prognostic role of pretreatment epidermal growth factor receptor T790M mutation in advanced non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitors
por: Ma, Guangzhi, et al.
Publicado: (2017)

Clinicopathological and prognostic features of surgically resected pathological stage I lung adenocarcinoma harboring epidermal growth factor receptor and K‐ras mutation
por: Kaseda, Kaoru, et al.
Publicado: (2017)

Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer.
por: Ravery, V., et al.
Publicado: (1995)

Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma
por: Kim, Hyeongbin, et al.
Publicado: (2019)

Peripheral Blood for Epidermal Growth Factor Receptor Mutation Detection in Non-Small Cell Lung Cancer Patients
por: Li, Xuefei, et al.
Publicado: (2014)

PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer
por: Ren, Zhixuan, et al.
Publicado: (2023)

Prognostic Value Analysis of Mutational and Clinicopathological Factors in Non-Small Cell Lung Cancer
por: Li, Chenguang, et al.
Publicado: (2014)

Epidermal growth factor receptor T790M mutation as a prognostic factor in EGFR-mutant non-small cell lung cancer patients that acquired resistance to EGFR tyrosine kinase inhibitors
por: Ma, Guangzhi, et al.
Publicado: (2017)

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.
por: Bartlett, J. M., et al.
Publicado: (1996)

Distinct expression and prognostic value of members of the epidermal growth factor receptor family in ovarian cancer
por: Zhou, Quan, et al.
Publicado: (2018)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases
por: Wang, Jing, et al.
Publicado: (2020)

Diagnostic Value of Mutation-Specific Antibodies for Immunohistochemical Detection of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis
por: Chen, Zi, et al.
Publicado: (2014)

Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors
por: Chang, Bee-Song, et al.
Publicado: (2022)

Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis
por: Zhang, Shi-Ming, et al.
Publicado: (2018)

Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer
por: Zhang, Liwen, et al.
Publicado: (2017)

Prognostic outcome of treatment modalities for epidermal growth factor receptor-mutated advanced lung cancer
por: Jang, Seung Hun, et al.
Publicado: (2022)

Prognostic and predictive value of serum carcinoembryonic antigen levels in advanced non-small cell lung cancer patients with epidermal growth factor receptor sensitive mutations and receiving tyrosine kinase inhibitors
por: Zhao, Xin Min, et al.
Publicado: (2017)

Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection
por: Wang, Xiaohong, et al.
Publicado: (2017)

Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer
por: Feng, Wen, et al.
Publicado: (2016)

Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer
por: Jiang, Richeng, et al.
Publicado: (2016)

Clinicopathological Features and Significance of Epidermal Growth Factor Receptor Mutation in Surgically Resected Early-Stage Lung Adenocarcinoma
por: Lu, Chao-Wen, et al.
Publicado: (2023)

Clinical significance of anemia as a prognostic factor in non-small cell lung cancer carcinoma with activating epidermal growth factor receptor mutations
por: Kang, Hye Seon, et al.
Publicado: (2020)

Heterogeneity of the resistance to gefitinib treatment in a non‐small cell lung cancer patient with active epidermal growth factor receptor mutation
por: Xu, Chong‐Rui, et al.
Publicado: (2016)

Prognostic model for brain metastases from lung adenocarcinoma identified with epidermal growth factor receptor mutation status
por: Li, Hongwei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1dm3c5agke5pm1nhd9s4979u2r